{"result": "(\"entity\"<|>VINAERS E<|>PERSON<|>Vinars E is an author who contributed to the history of parenteral nutrition in the medical literature.)\n##\n(\"entity\"<|>WILMORE D<|>PERSON<|>Wilmore D is a researcher known for his work on parenteral nutrition and its clinical applications.)\n##\n(\"entity\"<|>DUDRICK SJ<|>PERSON<|>Dudrick SJ is a pioneer in the development of total parenteral nutrition and has published extensively on the subject.)\n##\n(\"entity\"<|>MUNOZ PG<|>PERSON<|>Muñoz PG is an author involved in the consensus on pediatric parenteral nutrition.)\n##\n(\"entity\"<|>LOPEZ LG<|>PERSON<|>López LG is a contributor to the guidelines on pediatric parenteral nutrition.)\n##\n(\"entity\"<|>COSTA CM<|>PERSON<|>Costa CM is an author who has worked on pediatric nutrition topics.)\n##\n(\"entity\"<|>VILLARES JM<|>PERSON<|>Villares JM is involved in the consensus document on pediatric parenteral nutrition.)\n##\n(\"entity\"<|>GINER CP<|>PERSON<|>Giner CP is a contributor to the pediatric parenteral nutrition guidelines.)\n##\n(\"entity\"<|>MARISTANY CP<|>PERSON<|>Maristany CP is an author associated with pediatric nutrition research.)\n##\n(\"entity\"<|>DEL RIO MT<|>PERSON<|>Del Río MT is a contributor to the consensus on pediatric parenteral nutrition.)\n##\n(\"entity\"<|>TAYLOR CJ<|>PERSON<|>Taylor CJ is a researcher who has reviewed the impact of multidisciplinary teams on patient outcomes in parenteral nutrition.)\n##\n(\"entity\"<|>GRIFFITHS RD<|>PERSON<|>Griffiths RD is a researcher who has contributed to studies on parenteral nutrition.)\n##\n(\"entity\"<|>FERNANDEZ RS<|>PERSON<|>Fernandez RS is involved in research related to pediatric nutrition.)\n##\n(\"entity\"<|>FIVEZ T<|>PERSON<|>Fivez T is a researcher who studied early versus late parenteral nutrition in critically ill children.)\n##\n(\"entity\"<|>KERNER JA<|>PERSON<|>Kerner JA is an author who has written about parenteral nutrition in pediatric care.)\n##\n(\"entity\"<|>BONNABRY P<|>PERSON<|>Bonnabry P is involved in improving safety in the production of pediatric parenteral nutrition solutions.)\n##\n(\"entity\"<|>CINGRIA L<|>PERSON<|>Cingria L is a researcher focused on pediatric nutrition safety.)\n##\n(\"entity\"<|>SADEGHIPOUR<|>PERSON<|>Sadeghipour is involved in the research of pediatric parenteral nutrition solutions.)\n##\n(\"entity\"<|>ING H<|>PERSON<|>Ing H is a contributor to studies on pediatric nutrition.)\n##\n(\"entity\"<|>FONZO-CHRISTE C<|>PERSON<|>Fonzo-Christe C is involved in pediatric nutrition research.)\n##\n(\"entity\"<|>PFISTER RE<|>PERSON<|>Pfister RE is a researcher focused on pediatric parenteral nutrition.)\n##\n(\"entity\"<|>ALONSO FRANCH M<|>PERSON<|>Alonso Franch M is an author who has written about nutritional requirements in pediatrics.)\n##\n(\"entity\"<|>CASTELLANO G<|>PERSON<|>Castellano G is involved in pediatric nutrition research.)\n##\n(\"entity\"<|>MORAIS LOPEZ A<|>PERSON<|>Moráis López A is an author who has provided practical advice for pediatric parenteral nutrition prescription.)\n##\n(\"relationship\"<|>VINAERS E<|>WILMORE D<|>Vinars E and Wilmore D collaborated on the history of parenteral nutrition<|>4)\n##\n(\"relationship\"<|>WILMORE D<|>DUDRICK SJ<|>Wilmore D and Dudrick SJ are both key figures in the development of parenteral nutrition<|>5)\n##\n(\"relationship\"<|>DUDRICK SJ<|>MUNOZ PG<|>Dudrick SJ and Muñoz PG contributed to the consensus on pediatric parenteral nutrition<|>4)\n##\n(\"relationship\"<|>MUNOZ PG<|>LOPEZ LG<|>Muñoz PG and López LG worked together on pediatric parenteral nutrition guidelines<|>4)\n##\n(\"relationship\"<|>COSTA CM<|>VILLARES JM<|>Costa CM and Villares JM are both involved in pediatric nutrition research<|>3)\n##\n(\"relationship\"<|>GINER CP<|>MARISTANY CP<|>Giner CP and Maristany CP contributed to pediatric nutrition studies<|>3)\n##\n(\"relationship\"<|>DEL RIO MT<|>TAYLOR CJ<|>Del Río MT and Taylor CJ have both published research on pediatric nutrition<|>3)\n##\n(\"relationship\"<|>FIVEZ T<|>KERNER JA<|>Fivez T and Kerner JA are both involved in pediatric nutrition research<|>3)\n##\n(\"relationship\"<|>BONNABRY P<|>CINGRIA L<|>Bonnabry P and Cingria L collaborated on improving safety in pediatric parenteral nutrition<|>4)\n##\n(\"relationship\"<|>SADEGHIPOUR<|>ING H<|>Sadeghipour and Ing H are both involved in pediatric nutrition research<|>3)\n##\n(\"relationship\"<|>FONZO-CHRISTE C<|>PFISTER RE<|>Fonzo-Christe C and Pfister RE are both researchers in pediatric parenteral nutrition<|>3)\n##\n(\"relationship\"<|>ALONSO FRANCH M<|>CASTELLANO G<|>Alonso Franch M and Castellano G have both contributed to pediatric nutrition guidelines<|>4)\n##\n(\"relationship\"<|>MORAIS LOPEZ A<|>MUNOZ PG<|>Moráis López A and Muñoz PG are both involved in pediatric parenteral nutrition<|>4)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: ibilidades del hospital. La familia debe ser adecuadamente entrenada para poder realizar el tratamiento de forma segura y el paciente debe estar en una situación clínica estable. Es fundamental considerar que si no existe una familia muy motivada y dispuesta a asumir las responsabilidades de la NPD y a seguir el programa de enseñanza, no es posible plantear en un niño una NPD90.\n\n## 12. Resumen y conclusiones\n\nLa NP continúa siendo un arma terapéutica eficaz que sigue salvando vidas. Aunque su empleo está asociado a complicaciones, su uso racional por personal experimentado contribuye a disminuir las mismas. Por sus especiales características fisiológicas y sus diferentes requerimientos, los datos procedentes de los adultos no son extrapolables a los niños; ni tan siquiera los de estos a los RNPT. Aunque la nutrición enteral ha experimentado un auge importante en los últimos años, el uso combinado de ambas técnicas de soporte nutricional enriquece el arsenal terapéutico en determinados grupos de enfermos. El empleo de nutrientes específicos abre campos interesantes, pues permitirán no solo el soporte nutricional del paciente, sino modificar el curso clínico de la enfermedad al interferir en los mecanismos inflamatorios o, por extensión, en la respuesta metabólica a la agresión.\n\n## 13. Bibliografía\n\n1. Vinars E, Wilmore D. History of parenteral nutrition. JPEN J Parent Ent Nutr. 2003; 27: 225-32.\n2. Dudrick SJ. Early developments and clinical applications of total parenteral nutrition. JPEN J Parent Ent Nutr2003; 27: 291-9.\n3. Wilmore DW, Dudrick SJ. Growth and development of an infant receiving all nutrients via a vein. JAMA. 1968; 20: 860-4.\n4. AGA Technical Review on Parenteral nutrition. Gastroenterology 2001; 121:970-1001.\n5. Schewnk WF. Specialized nutrition support: the pediatric perspective. JPEN J Parent Ent Nutr. 2003; 27: 160-7.\n6. Kerner JA. Parenteral Nutrition. En: Walker WA, Watkins JB, Duggan Ch. Nutrition in Pediatrics. 5th ed. London: BC Decker Inc; 2003. p. 957-85.\n7. Muñoz PG, López LG, Costa CM, Villares JM, Giner CP, Maristany CP, del Río MT; Spanish Society of Parenteral and Enteral Nutrition; Spanish Society of Gastroenterology, Hepatology and Nutrition; Spanish Society of Hospital Pharmacies. [Consensus on paediatric parenteral nutrition: a document approved by SENPE/SEGHNP/SEFH]. Nutr Hosp. 2007; 22(6):710-9.\n8. Taylor CJ, Griffiths RD, Fernandez RS. Does a multidisciplinary total parenteral nutrition team improve patient outcomes? A systematic review. JPEN J Parent Ent Nutr. 2004; 28: 251-8.\n9. Moreno Villares JM, Pedrón Giner C. Nutrición artificial en el paciente pediátrico. En: Gil A. Tratado de nutrición. 2ª ed. Madrid: EM Panamericana; 2010. p. 171-200.\n10. Collier S, Gura KM, DeLoid L, Dalton M, Summers L. Parenteral Nutrition. In: Sonneville K, Duggan C. Manual of Pediatric Nutrition. 5th ed. London: BC Decker; 2013. p. 196-215.\n11. Fivez T, Kerklaan D, Mesotten D, Verbruggen S, Wouters PJ, Vanhorebeek I, et a. Early versus late parenteral nutrition in critically ill children. N Engl J Med 2016; 374: 1112-22.\n12. Koletzko B, Goulet O, Hunt J, et al. Organisational aspects of hospital PN. En: Guidelines on pediatric parenteral nutrition of the European Society of Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) and the European Society for Clinical Nutrition and Metabolism (ESPEN); supported by the European Society for Pediatric Research (ESPR): JPediatr Gastroenterol Nutr 2005; 41: S63-S69.\n13. Bonnabry P, Cingria L, Sadeghipour, Ing H, Fonzo-Christe C, Pfister RE. Use of a systematic risk analysis method to improve safety in the production of paediatric parenteral nutrition solutions. Qual Saf Health Care. 2005; 14:93-8.\n14. Alonso Franch M, Castellano G. Conceptos generales de nutrición. Requerimientos nutricionales. En: Muñoz MT, Suárez L, eds. Manual práctico de nutrición en pediatría, 1.ª ed. Madrid: Ergon, 2007; 1-11.\n15. Moráis López A, Lama More RA, Galera Martínez R. Consejos prácticos para la prescripción de nutrición parenteral pediátrica. Acta Pediatr Esp. 2016; 74(2): 57\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>HOSPITAL<|>ORGANIZATION<|>The hospital is a healthcare institution that provides treatment and care for patients, including those requiring nutritional support.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>EVENT<|>Nutritional therapy that involves delivering nutrients directly into the bloodstream, often used for patients who cannot eat by mouth.)\n##\n(\"entity\"<|>FAMILIA<|>PERSON<|>The family is responsible for the care and treatment of the patient, requiring training to manage nutritional support effectively.)\n##\n(\"entity\"<|>NIÑO<|>PERSON<|>A child who may require nutritional support through parenteral nutrition due to medical conditions.)\n##\n(\"entity\"<|>RNPT<|>PERSON<|>Refers to premature infants who may have specific nutritional needs that differ from older children and adults.)\n##\n(\"entity\"<|>ESPANOL SOCIETY OF PARENTERAL AND ENTERAL NUTRITION<|>ORGANIZATION<|>A professional organization that focuses on the guidelines and consensus for pediatric parenteral nutrition.)\n##\n(\"relationship\"<|>HOSPITAL<|>NUTRICIÓN PARENTERAL<|>The hospital provides parenteral nutrition as a therapeutic option for patients who cannot consume food orally<|>8)\n##\n(\"relationship\"<|>FAMILIA<|>NIÑO<|>The family is responsible for the care of the child, especially in managing nutritional support<|>7)\n##\n(\"relationship\"<|>NIÑO<|>RNPT<|>The child may be a premature infant requiring specialized nutritional support<|>6)\n##\n(\"relationship\"<|>ESPANOL SOCIETY OF PARENTERAL AND ENTERAL NUTRITION<|>HOSPITAL<|>The organization provides guidelines that hospitals follow for administering parenteral nutrition<|>5)\n<|COMPLETE|>"}]}